DinaBio Launches MethyPure-08 Fully Automated Methylation Pretreatment System to Advance Cancer Screening Accessibility
DinaBio’s MethyPure-08 Fully Automated Methylation Preprocessing System integrates nucleic acid extraction and bisulfite conversion into a seamless, one-stop automated workflow, effectively minimizing operational errors, freeing up hands, and enhancing efficiency.
This instrument is widely applicable in molecular diagnostics, clinical testing, disease prevention and control, inspection and quarantine, and molecular biology research, providing laboratories with a simple, efficient, precise, reliable, cost-effective, and highly adaptable automated solution for nucleic acid sample pretreatment.
On Tuesday, October 17, at 19:30, the 32nd session of VCBeat Select New Product Showcase will feature Li Jin, Co-founder of Dina Bio, who will present on the Fully Automated Methylation Pre-treatment Instrument.
Low cost
Fully independently developed, closed system of equipment and reagents, simple product design, and low cost of reagents and consumables.
Simple and Rapid
Foolproof operation: one-step sample loading completes sample methylation pretreatment within 2 hours.
Customizable
The device features a stable structure and lightweight design, facilitating the rapid implementation of tumor methylation projects. Customized development services are also available.
Fully Automated Methylation Preprocessing
Capable of nucleic acid extraction and bisulfite conversion for samples such as blood, urine, feces, secretions, cells, and tissues, achieving one-step sample loading and fully automated processing without manual intervention.
Compatible with nucleic acid extraction function, large capacity
Capable of processing individual sample volumes up to 2 mL, meeting the requirements for large-volume sample experiments.
Ultra-Quiet Operation
Innovative rotational mixing technology with an operating noise level of ≤65 dB.
High extraction efficiency
Nucleic acid recovery rate > 95%, magnetic bead residue < 1%, inter-well CV < 3%.
Scan the QR code on the poster to add our assistant and reserve your spot for the live broadcast!
Li Jin
Dina Bio | Co-Founder
Formerly served as Regional Director at Kangmei Pharmaceutical Co., Ltd., Marketing Director for the Yaodutang Project at Renhe Pharmaceutical, and Head of Electrochemical Project Management for the China region at UCLA-EzlifeGZ (a Sino-US joint venture).
Has successively participated in multiple major national, provincial, and ministerial-level scientific research projects, as well as industrialization projects under the National Development and Reform Commission (NDRC). Currently ongoing project: Portable fully automated molecular POCT rapid diagnostic instrument and supporting reagent kits (benchmarked against U.S. Cepheid and FilmArray systems).
With 20 years of marketing and management experience in the biopharmaceutical industry. Involved in the R&D and commercialization of pharmaceuticals (traditional Chinese medicine, Western medicine, and Chinese herbal materials), medical devices, and medical analytical instruments. Previously held marketing and operational management positions at three domestically listed companies.
About Dina Bio
Guangzhou DinaBio Biotechnology Co., Ltd. (DinaBio.), established in 2019, is a high-tech biotechnology company integrating research and development, production, and sales. Guided by its mission of “Precision Diagnostics Accessible to All,” the company adheres to its core values of “Customer Satisfaction, Striving as the Foundation, Innovation and Pragmatism, and Pursuit of Excellence.” Focusing on “disruptive” innovative applications in molecular diagnostics, DinaBio. integrates multiple technologies including microfluidics, full automation, AI analysis, PCR, electrochemistry, and semiconductors. In 2023, the company launched its “Desktop · Fully Automated” product series, comprising the MethyPure™ series, as well as the GenCaste, GenFaster, and GenMaster series.
About VCBeat's New Product Selection and Tasting
“Artery Select New Product Launch” is a live-streaming program under the “Artery Select” brand, dedicated to supporting medical enterprises in launching innovative products. The program’s mission is to empower every milestone launch of innovative medical products.
Scan the QR code below to contact the assistant and schedule a live stream.
(If already added, please proactively contact the assistant)
